Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How much does focalin cost?Rexulti generic release date in ontario?Edurant patent cliff?Dupixent ablauf patent?Phendimetrazine 35 mg?
See the DrugPatentWatch profile for Fycompa
Fycompa is the brand name for perampanel, an anti-seizure medicine used to treat certain forms of epilepsy.
Fycompa/perampanel is prescribed for partial-onset seizures (focal seizures) in people with epilepsy, typically as an add-on (adjunctive) therapy. It may also be used for primary generalized tonic-clonic seizures in some treatment settings, depending on local prescribing guidance.
Fycompa was developed and marketed by Eisai.
If you’re looking for details such as patent status or exclusivity information related to perampanel/Fycompa, DrugPatentWatch tracks these kinds of updates and documents: https://www.drugpatentwatch.com/
Other Questions About Fycompa :